Close

UPDATE: Needham & Company Starts Taysha Gene Therapies (TSHA) at Buy, $45 PT

July 15, 2021 4:16 PM EDT Send to a Friend
(Updated - July 15, 2021 4:53 PM EDT)

Needham & Company analyst Gil Blum initiates coverage on Taysha Gene ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login